Book an Appointment

Male Female
No file chosen

Dr Gaurav Goel

Surgical Oncology


Dr Gaurav Goel

Consultant – Surgical Oncology

DNB - Surgical Oncology


Educational Background:

  • MBBS
  • DNB
  • SR in Surgical Oncology



  • Dr Gaurav Goel is a Surgical Oncologist at HCG Cancer Centre, Jaipur who is experienced in Onco Surgical procedures with a special interest in Head & Neck, Breast, Gynaecological & GI Malignancies and Colorectal cancers
  • His secondary interest lies in treating Soft Tissue Cancer, Sarcomas and Thoracic Malignancies



  • Goel G, Janaki PD, Anupama R et al. Predicting Nodal Burden in Clinically N0 Breast Cancer: A Comparison between Ultrasound-Guided Fine Needle Aspiration Cytology (FNAC) and Sentinel Lymph Node Biopsy (SLNB) Indian J Gynecol Oncolog (2017) 15:33.
  • Anupama R, Indu R, Goel G et al.Evaluating the Impact of Frozen Section Analysis in Surgery for Ovarian Neoplasms. Indian J GynecolOncolog (2015)13:7.
  • Venkatesan R, Bagul KG, Goel G et al. Does Axillary Tucking During Modified Radical Mastectomy Reduce Seroma Formation? – a Randomised Control Trial in 100 Patients. Clinical Oncology 29 (3):e 78 March 2017.
  • Goel G, Anupama R, Sandhya CJ et al. A Prospective Observational Study Evaluating the Accuracy of MRI in Predicting the Extent of Disease in Endometrial Cancer. Indian J Surg Oncol (2018) 10 (1).
  • Agarwal R, Anupama R, Goel G et al. A Comparison of the Clinical Outcomes in Uterine Cancer Surgery After the Introduction of Robotic-Assisted Surgery. Journal of Obstetrics and Gynecology of India( 2018) 69(7).
  • Agarwal R, Philip A, Pavithran K, Anupama R, Goel G etal.Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy. Indian Journal of Cancer (2019),56(3): 228-35
  • Agarwal R, Anupama R, Nitu PV, Goel G et al. A prospective study evaluating the impact of implementing the ERAS protocol on patients undergoing surgery for advanced ovarian cancer. International Journal of Gynecological Cancer (2019) 29(2 Pt 1)
<style type="text/css">.tb_button {padding:1px;cursor:pointer;border-right: 1px solid #8b8b8b;border-left: 1px solid #FFF;border-bottom: 1px solid #fff;}.tb_button.hover {borer:2px outset #def; background-color: #f8f8f8 !important;}.ws_toolbar {z-index:100000} .ws_toolbar .ws_tb_btn {cursor:pointer;border:1px solid #555;padding:3px} .tb_highlight{background-color:yellow} .tb_hide {visibility:hidden} .ws_toolbar img {padding:2px;margin:0px} </style>